Cord blood is the blood that remains in the umbilical cord and placenta after a baby is delivered. In the past, cord blood was traditionally discarded as medical waste. However, following years of research, medical scientists have now applied the stem cells found in cord blood to successfully treat over 80 diseases!

Thus far, cord blood stem cells have been successfully used to treat numerous diseases, including cancers (such as leukemia, lymphomas, myelomas), blood disorders (such as thalassemias, sickle cell anemia, Fanconi’s anemia), and immune deficiency diseases. Please refer to all treatable diseases. Recently, cord blood stem cells have been used in clinical trials to repair damaged tissues and organs (regenerative medicine), and the outcomes have been promising.

Following your baby's birth, your healthcare provider will collect a 15cm segment of the umbilical cord, known as cord tissue. This tissue, along with cord blood, can be processed using Progenics’ cord tissue collection kit. Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) are found to possess more primitive properties than adult Mesenchymal Stem Cells, exhibiting greater expansion ability and faster doubling time, making them potentially valuable for clinical use.

Cord tissue, particularly the Wharton’s Jelly portion preserved in our lab, is a rich source of Mesenchymal Stem Cells (MSCs). These cells can self-regenerate and differentiate into specialized cells like bone, cartilage, and fat cells, holding promise for regenerative medicine with reduced risk of rejection and transplant complications.